Search

everythinglearnresearchcommunity

for

Search:↓

Vitiligo patients should be routinely screened for thyroid disease and, if extensive or prolonged, also for RA, PA, and type 2 diabetes.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Skin changes are key for early diagnosis and treatment of rheumatic diseases.

More precise, personalized therapies are needed for autoimmune diseases.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

A man with four autoimmune diseases suggests a new category for multiple autoimmune syndrome.

An 18-year-old girl improved with treatment after being diagnosed with both Systemic Lupus Erythematosus and Celiac Disease.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Vitamin D is crucial for skin health and managing skin diseases.

A girl with hereditary chorea, likely Huntington's disease, had her condition worsened by lupus.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Thyroid problems are linked to various skin issues, and checking thyroid health is important for people with certain skin conditions.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

The document explains various skin conditions and their treatments.